miocamycin miocamycin miocamycin is a macrolide antibiotic. it has a spectrum activity similar to that of erythromycin, but shows higher antimicrobial effect against certain bacteria including legionella pneumophila (the causative agent of legionnaires' disease), mycoplasma hominis, and ureaplasma urealyticum. in-vivo studies have further expounded on miocamycin's efficacy, reporting that the medication is more effective than in-vitro data suggests. miocamycinclinical dataahfs/drugs.cominternational drug namesatc codej01fa11 (who) identifiers iupac name (2s,3s,4r,6s)-6--4-(dimethylamino)-5-hydroxy-2-methyloxan-3-yl]oxy}-2,4-dimethyl-3-propoxyoxan-4-yl acetate cas number55881-07-7pubchem cid6475694chemspider16735908 yunii3t48cps7u2chemblchembl1091024 ycomptox dashboard (epa)dtxsid60905087 echa infocard100.054.418 chemical and physical dataformulac45h75no15molar mass870.087 g·mol−13d model (jsmol)interactive imagemelting point220 °c (428 °f)solubility in waterslightly soluble in water; soluble in methanol, acetone and chloroform. mg/ml (20 °c) smiles cc(=o)o3/c=c/c=c/c(c)oc(=o)c(oc(=o)cc)(oc)(o2o(c)(o1c(c)(oc(c)=o)(oc(=o)cc)(c)o1)(n(c)c)2o)(cc=o)c3c inchi inchi=1s/c45h71no17/c1-13-34(50)59-33-23-36(52)55-26(4)18-16-15-17-19-32(58-29(7)48)25(3)22-31(20-21-47)41(42(33)54-12)62-44-39(53)38(46(10)11)40(27(5)57-44)61-37-24-45(9,63-30(8)49)43(28(6)56-37)60-35(51)14-2/h15-17,19,21,25-28,31-33,37-44,53h,13-14,18,20,22-24h2,1-12h3/b16-15+,19-17+/t25-,26-,27-,28+,31+,32+,33-,37+,38-,39-,40-,41+,42+,43+,44+,45-/m1/s1 ykey:gqnzgcarkrhpoh-rqikctsvsa-n y (verify)